1. FRI0128 Prism – pictorial representation of illness and self measure: the use of a simple non-verbal tool as a patient-centred outcome measure in early rheumatoid arthritis cohorts. (15th June 2017) Authors: Taylor, PC; Alten, R; Haraoui, B; Amess, B; Macdonald, J; Truchon, M; Pohl, C; Swales, C; Kaneko, Y; Sensky, T Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A7.16 Characterisation of changes in lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis in two phase 3 studies. (24th February 2016) Authors: Emery, P; McInnes, I; Genovese, MC; Smolen, JS; Kremer, J; Dougados, M; Schlichting, DE; Rooney, T; Issa, M; de Bono, S; Macias, WL; Rogai, V; Zuckerman, SH; Taylor, PC Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study. (2nd January 2022) Authors: Uhrenholt, L; Christensen, R; Dreyer, L; Schlemmer, A; Hauge, E-M; Krogh, NS; Abildtoft, MK; Taylor, PC; Kristensen, S Journal: Scandinavian journal of rheumatology Issue: Volume 51:Number 1(2022) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A7.17 Effects of baricitinib on multibiomarker disease activity scores and their components in a phase 2b study in moderate-to-severe rheumatoid arthritis patients. (24th February 2016) Authors: Taylor, PC; Genovese, MC; Keystone, E; Weinblatt, M; Rancourt, J; Nantz, E; Schlichting, DE; Zuckerman, SH; Macias, WL Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P059 Ex vivo comparison of baricitinib, upadacitinib, filgotinib and tofacitinib for cytokine signalling in human leukocyte subpopulations. (21st February 2018) Authors: McInnes, IB; Higgs, R; Lee, J; Macias, WL; Na, S; Ortmann, RA; Rocha, G; Wehrman, T; Zhang, X; Zuckerman, SH; Taylor, PC; Perrier, C Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB1155 Depression and suicidality are common in psoriatic arthritis and axial spondyloarthritis, and rates are comparable to those in psoriasis. (15th June 2017) Authors: Sheahan, A; Suruki, R; Taylor, PC; Sloan, VS Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P092 Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study. (21st February 2018) Authors: Emery, P; Taylor, PC; Weinblatt, ME; Tanaka, Y; Keystone, EC; Dow, ER; Higgs, R; Macias, WL; Rocha, G; Rooney, TP; Schlichting, DE; Zuckerman, SH; McInnes, IB; Holzkaemper, T Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗